Continuously infused amphotericin B deoxycholate for primary treatment of invasive fungal disease in acute myeloid leukaemia

2018 ◽  
Vol 36 (2) ◽  
pp. 471-480
Author(s):  
Christoph Rothenbühler ◽  
Ulrike Held ◽  
Markus G. Manz ◽  
Urs Schanz ◽  
Bernhard Gerber
2021 ◽  
Author(s):  
Daniel K. Yeoh ◽  
Andrew S. Moore ◽  
Rishi S. Kotecha ◽  
Adam W. Bartlett ◽  
Anne L. Ryan ◽  
...  

Mycoses ◽  
2010 ◽  
Vol 54 (4) ◽  
pp. e92-e98 ◽  
Author(s):  
Christina T. Rieger ◽  
Saskia Huppmann ◽  
Lisa Peterson ◽  
Heidi Rieger ◽  
Helmut Ostermann

Oncoreview ◽  
2016 ◽  
Vol 6 (4) ◽  
pp. 0-0
Author(s):  
Jan Styczyński

This paper reports on diagnostic and therapeutic management of pulmonary invasive fungal disease (IFD) in a child with relapsed acute myeloid leukaemia, undergoing chemotherapy followed by hematopoietic stem cell transplantation. Surgical management with resection of the involved lung tissue was based on the location of fungal infiltrates close to large circulatory vessels. After examination of resected pulmonary tissue, a diagnosis of proven IFD was done. This case report is an example that aspergillosis is usually the cause for pulmonary IFD. Pharmacotherapy of pulmonary IFD should be based on compounds with good penetration to lung tissue: amphotericin B lipid form or voriconazole.


2019 ◽  
Vol 19 (4) ◽  
pp. 233-234
Author(s):  
Jorrit Schaefer ◽  
Sorcha Cassidy ◽  
Rachel M. Webster

Sign in / Sign up

Export Citation Format

Share Document